Common questions researchers ask about CJC-1295 (no DAC) — laboratory context only.
What does "no DAC" mean?
It refers to the absence of the Drug Affinity Complex modification used in the longer-acting CJC-1295 (DAC) variant. The no-DAC form is the modified-GHRH-fragment backbone alone, without the albumin-binding moiety, giving it a materially shorter research half-life — a distinction explained in its mechanism of action.
Is no-DAC CJC-1295 the same as Mod GRF (1-29)?
The two names are frequently used for functionally similar modified-GHRH-fragment peptides in the literature; the shared structural logic (stabilizing substitutions on the same 29-residue GHRH fragment used in sermorelin) is covered in the chemistry article.
Why pair it with ipamorelin in research?
The GHRH-mimetic and ghrelin-mimetic pathways converge on GH release; see the paired-secretagogue research article.
How is it supplied and handled?
Lyophilized powder, kept cold and dark; general handling is in reconstitution and storage.
What documentation should accompany a lot?
A lot-specific certificate of analysis with HPLC purity and mass-spec identity — see how to read a CoA.
Product page: CJC-1295 (No DAC) research vials.
Research Use Only. Supplied strictly for laboratory research and development — not for human or veterinary use, consumption, or any therapeutic or diagnostic purpose. This article is research education, not usage guidance.
